Cytokine Level and Symptoms of Schizophrenia
DOI:
https://doi.org/10.3889/oamjms.2021.6322Keywords:
Cytokines, Tumor necrosis factor-alpha, SchizophreniaAbstract
BACKGROUND: The study was intended to find one of the cytokines, that is, tumor necrosis factor (TNF)-alpha correlation with PANSS scores of people with schizophrenia (PwS) and their differences compared to the healthy people of Malayan- Mongoloid Race.
AIM: The aim of this study was providing a profile of TNF-alpha level in PwS of Malayan-Mongoloid race and its correlation with positive and negative symptoms in schizophrenia.
METHODS: It was conducted using cross-sectional and following sampling methods, with inclusion and exclusion criteria set for the PwS and control groups.
RESULTS: The result was no correlation between TNF-alpha levels with PANSS scores on PwS (p > 0.005), with very weak correlation and positive correlation direction, and there were differences in TNF-alpha levels.between PwS and control groups.
CONCLUSION: It can be concluded that the higher levels of TNF-alpha would impact on the severity symptoms experienced by PwS.Downloads
Metrics
Plum Analytics Artifact Widget Block
References
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Philadelphia, PA: American Psychiatric Publishing; 2013.
Fan X, Goff DC, Hederson DC. Inflammation and schizophrenia. Expert Rev Neurother. 2007;7(7):789-96. PMid:17610386
Naudin J, Capo C, Giusan B, Mège JL, Azorin JM. A differential role for interleukin-6 and tumor necrosis factor-alpha in schizophrenia? Schizophr Res. 1997;26(2-3):227-33. https://doi.org/10.1016/s0920-9964(97)00059-5 PMid:9323355 DOI: https://doi.org/10.1016/S0920-9964(97)00059-5
Erbagci AB, Herken H, Köyloüglu O, Yilmaz N, Tarakçioglu M. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment. Mediators Inflamm. 2001;10(3):109-15. https://doi.org/10.1080/09629350123895 PMid:11545247 DOI: https://doi.org/10.1080/09629350123895
Kowalski J, Blada P, Kucia K, Madej A, Herman ZS. Neuroleptics normalize increased release of interleukin- 1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia. Schizophr Res. 2001;50(3):169-75. https://doi.org/10.1016/s0920-9964(00)00156-0 PMid:11439237 DOI: https://doi.org/10.1016/S0920-9964(00)00156-0
Theodoropoulou S, Spanakos G, Baxevanis CN, Economou M, Gritzapis AD, Papamichail MP, et al. Cytokine serum levels, autologous mixed lymphocyte reaction and surface marker analysis in never medicated and chronically medicated schizophrenic patients. Schizophr Res. 2001;47(1):13-25. https://doi.org/10.1016/s0920-9964(00)00007-4 PMid:11163541 DOI: https://doi.org/10.1016/S0920-9964(00)00007-4
O’Brien SM, Scully P, Dinan TG. Increased tumor necrosis factor-alpha concentrations with interleukin-4 concentrations in exacerbations of schizophrenia. Psychiatry Res. 2008;160(3):256-62. https://doi.org/10.1016/j.psychres.2007.11.014PMid:18722671
Tian L, Tan Y, Chen D, Lv M, Tan S, Soares JC, et al. Reduced serum TNF alpha level in chronic schizophrenia patients with or without tardive dyskinesia. Prog Neuropsychopharmacol Biol Psychiatry. 2014;54:269-4. https://doi.org/10.1016/j.pnpbp.2014.06.012 PMid:24995685 DOI: https://doi.org/10.1016/j.pnpbp.2014.06.012
Lv MH, Tan Y.L, Yan SX, Tian L, Chen DC, Tan SP, et al. Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: Correlation with psychopathology and cognition. Psychopharmacology. 2015;232(1):165-72. https://doi.org/10.1007/s00213-014-3650-y PMid:24958229 DOI: https://doi.org/10.1007/s00213-014-3650-y
Zhu F, Zhang L, Liu F, Wu R, Guo W, Ou J, et al. Altered serum tumor necrosis factor and interleukin-1β in first-episode drug-naive and chronic schizophrenia. Front Neurosci. 2018;12:296. https://doi.org/10.3389/fnins.2018.00296 PMid:29867314 DOI: https://doi.org/10.3389/fnins.2018.00296
Li R, Ma X, Wang G, Yang J, Wang C. Why sex differences in schizophrenia? Transl Neurosci (Beijing). 2016;1(1):37-42. PMid:29152382
Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J. Gender differences in schizophrenia and first-episode psychosis: A comprehensive literature review. Schizophr Res Treatment. 2012;2012:916198. https://doi.org/10.1155/2012/916198 PMid:22966451 DOI: https://doi.org/10.1155/2012/916198
Ergün S, Yanartaş Ö, Kandemir G, Yaman M, Haklar G, Sayar K. The relationship between psychopathology and cognitive functions with cytokines in clinically stable patients with schizophrenia. Psychiatry Clin Psychopharmacol. 2017;28(1):66-72. https://doi.org/10.1080/24750573.2017.1380920 DOI: https://doi.org/10.1080/24750573.2017.1380920
Kubistova A, Horacek J, Novak T. Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls. Psychiatr Danub. 2012;24 Suppl 1:S153-6. PMid:22945211
Ajami A, Abedian F, Hosseini SH, Akbarian E, Alizadeh- Navaei R, Taghipour M. Serum TNF-α, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine. Iran J Immunol. 2014;11(3):200-9. PMid:25265997
Luo Y, He H, Zhang J, Ou Y, Fan N. Changes in serum TNF-α, IL-18, and IL-6 concentrations in patients with chronic schizophrenia at admission and at discharge. Compr Psychiatry. 2019;90:82-7. https://doi.org/10.1016/j.comppsych.2019.01.003 PMid:30782515 DOI: https://doi.org/10.1016/j.comppsych.2019.01.003
Turhan L, Batmaz S, Kocbiyik S, Soygur AH. The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia. Nord J Psychiatry. 2016;70(5):342-50. https://doi.org/10.3109/08039488.2015.1122079 PMid:26754110 DOI: https://doi.org/10.3109/08039488.2015.1122079
Simamora RH, Loebis B, Husada MS. Comparison of serum levels of tumor necrosis factor alpha (TNF-α) in batak male schizophrenic patients versus. Int J Life Sci Sci Res. 2018;4(2):1652-6. https://doi.org/10.21276/ijlssr.2018.4.2.6 DOI: https://doi.org/10.21276/ijlssr.2018.4.2.6
Pollmächer T, Haack M, Schuld A, Reichenberg A, Yirmiya R. Low levels of circulating inflammatory cytokines-do they affect human brain functions? Brain Behav Immun. 2002;16(5):525-32. https://doi.org/10.1016/s0889-1591(02)00004-1 PMid:12401466 DOI: https://doi.org/10.1016/S0889-1591(02)00004-1
Hoseth EZ, Ueland T, Dieset I, Birnbaum R, Shin JH, Kleinman JE, et al. A study of TNF pathway activation in schizophrenia and bipolar disorder in plasma and brain tissue. Schizophr Bull. 2017;43(4):881-90. https://doi.org/10.1093/schbul/sbw183 PMid:28049760 DOI: https://doi.org/10.1093/schbul/sbw183
Mansur RB, Zugman A, Asevedo EM, da Cunha GR, Bressan RA, Brietzke E. Cytokines in schizophrenia: Possible role of anti-inflammatory medications in clinical and preclinical stages. Psychiatry Clin Neurosci. 2012;66(4):247-60. https://doi.org/10.1111/j.1440-1819.2012.02354.x PMid:22624729 DOI: https://doi.org/10.1111/j.1440-1819.2012.02354.x
Ferguson SA, Panos J, Varma V; 2019. Avalilable from: https://www.fda.gov/media/97461/download. [Last accessed on 08 Aug 2020].
Brody GH, Yu T, Miller GE, Chen E. Discrimination, racial identity, and cytokine levels among african american adolescents. J Adolesc Health. 2015;56(5):496-501. https://doi.org/10.1016/j.jadohealth.2015.01.017 PMid:25907649 DOI: https://doi.org/10.1016/j.jadohealth.2015.01.017
Brown MD, Fairheller DL, Thakkar S, Veerabhadrappa P, Park JY. Racial differences in tumor necrosis factor-alpha-induced endothelial microparticles and interleukin-6 production. Vasc Health Risk Manag. 2011;7:541-50. https://doi.org/10.2147/vhrm.s22930 PMid:21966220 DOI: https://doi.org/10.2147/VHRM.S22930
Liu ZH, Ding YL, Xiu LC, Pan HY, Liang Y, Zhong SQ, et al. A meta-analysis of the association between TNF-alpha- 308G > a polymorphism and Type 2 diabetes mellitus in Han Chinese population. PLoS One. 2013;8(3):e59421. https://doi.org/10.1371/journal.pone.0059421 PMid:23527193 DOI: https://doi.org/10.1371/journal.pone.0059421
Nomura T, Honda T, Kabashima K. Multipolarity of cytokine axes in the pathogenesis of atopic dermatitis in terms of age, race, species, disease stage and biomarkers. Int Immunol. 2018;30(9):419-28. https://doi.org/10.1093/intimm/dxy015 PMid:29518197 DOI: https://doi.org/10.1093/intimm/dxy015
Haralambieva IH, Ovsyannikova IG, Kennedy RB, Larrabee BR, Pankratz VS, Poland GA. Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals. Hum Immunol. 2013;74(10):1263-6. https://doi.org/10.1016/j.humimm.2013.06.031 PMid:23806267 DOI: https://doi.org/10.1016/j.humimm.2013.06.031
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2021 Mustafa Mahmud Amin, Elmeida Effendy (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0